Wayne Brinster

Wayne Brinster is Chief Executive Officer of PreciseDx and is a recognized, successful serial CEO. Prior to joining PreciseDx in 2021, Wayne was President and CEO of MedTech, where he orchestrated a complete business reorganization to align with a more strategic, market-focused vision and growth strategy. Prior to MedTest, Wayne was President and CEO of Wheaton Industries / DWK for five years where he led a major company restructuring, including new acquisitions and European expansion, generating sales growth and EBITDA improvement. Both assignments resulted in successful exits to market-leading strategic purchasers. Prior positions include Vice President and General Manager of the Cancer Diagnostic group, where he led the worldwide effort to develop and release several diagnostic tests for cancer using both imaging and molecular markers. Wayne had full P&L responsibility for R&D, Regulatory, Quality, Sales, Marketing, and Supply Chain management. Additional positions include Vice President and General Manager at Becton Dickinson and Vice President of Growth and Strategy at BD Diagnostics. Wayne holds a Bachelor of Science from the University of Miami, as well as several commercial board and leadership positions.